Literature DB >> 12488619

A Model for UV-Induction of Skin Cancer.

Allal Ouhtit, Honnavara N. Ananthaswamy.   

Abstract

Entities:  

Year:  2001        PMID: 12488619      PMCID: PMC79671          DOI: 10.1155/S1110724301000031

Source DB:  PubMed          Journal:  J Biomed Biotechnol        ISSN: 1110-7243


× No keyword cloud information.
The cellular and molecular events that contribute to the development of UV-induced skin cancer is a complex process involving at least two distinct pathways that interact or converge to cause skin cancer (Figure 1). One pathway involves the action of UV on target cells (keratinocytes) for neoplastic transformation, and the other involves the effects of UV on the host's immune system [1]. There is evidence to indicate that UV-induced DNA damage plays an important role in both pathways.
Figure 1

Pathways involved in skin cancer development.

Pathways involved in skin cancer development. In the normal human epidermis, cells are constantly turning over, about once a month. During this period, stem cells in the basal layer undergo cell division, and the keratinocytes differentiate into squamous cells producing keratin and other proteins, and finally desquamate. Chronic exposure to sunlight causes damage to the skin including erythema, edema, hyperplasia, formation of sunburn cells, photoaging, suppression of the immune system and skin cancer. Some of the molecular events that occur in cells following UV exposure are DNA damage, induction of p53 and p53-regulated proteins, cell cycle arrest, DNA repair, and apoptosis. UV-induced DNA damage causes an elevation of p53 expression and p53 protein is translocated to the nucleus to regulate its downstream genes. Among these genes, p21waf1/Cip1 expression is induced to mediate cell cycle arrest at G1-S phase to allow the repair of DNA damage. UV can also induce apoptosis to order cells containing damaged DNA to self-destruct. It has been shown that UV-induced apoptosis is p53-dependent [2]. Interestingly, we have recently demonstrated that p53 may up-regulate bax and down-regulate Bcl-2 protein resulting in apoptosis [3] and that Fas/Fas-ligand pathway is essential for UV-induced apoptosis [4]. Following chronic UV exposure, errors associated with DNA repair and/or replication can result into mutations in the p53 gene, especially C → T or CC → TT transitions, considered as UV-molecular signature. The p53 mutation in keratinocytes is probably an initiating event in UV skin carcinogenesis [5]. Because cells containing p53 mutations are relatively more resistant to UV-induced apoptosis, they can acquire a growth advantage. It is likely that the mutated cells expand preferentially in a clonal fashion at the expense of the normal surrounding keratinocytes, that commit massive suicide by apoptosis, leading to the appearance of p53 mutated clones in the epidermis [5, 6, 7]. Chronic exposure to sunlight may cause mutations in the other p53 allele and/or other unknown gene(s). Thus, another tumor suppressor gene known as patched (ptc) has been implicated in the development of basal cell carcinoma (BCC) [8, 9]. The human ptc gene was found to colocalize with the map location of nevoid basal cell carcinoma syndrome (NBCCS) on chromosome 9 at 9q22.3. NBCCS, also called basal cell nexus syndrome or Gorlin's syndrome, is a rare autosomal dominant disorder characterized by multiple BCC that appear at a young age on sun-exposed areas of the skin. Studies of NBCCS patients have shown that they have both genomic and sporadic mutations in the ptc gene, suggesting that these mutations are the ultimate cause of this disease. Sporadic ptc mutations have been found in BCC from otherwise normal individuals, some of which are UV-signature, either C → T or CC → TT changes. However, ptc mutations have not been reported in SCC. Nonetheless, these results suggest that genetic alterations in the ptc gene may also play a role in the development of BCC [9]. In addition, UV radiation causes immunosuppression that may contribute to the emergence of skin tumors. Immune suppression results from the induction of suppressor T cells, either by damaged Langerhans cells or inflammatory macrophages that enter the skin following UV exposure [10]. Another mechanism may be the release of cytokines such as IL-10, TNF-α, and IL-1α that can suppress the immune system and prevent T-cell mediated responses; these are known to be secreted by keratinocytes after UV damage [11]. In addition, UV irradiation can also convert normal skin chromophores into agents that are immunosuppressive, such as the conversion of trans-urocanic acid to cis-urocanic acid [12]. Thus, UV radiation plays a dual role in the development of skin cancer, by inducing genetic alterations in keratinocytes leading to their neoplastic transformation and by depressing the normal immune responses in the skin.
  12 in total

Review 1.  Mechanisms of induction of skin cancer by UV radiation.

Authors:  H Soehnge; A Ouhtit; O N Ananthaswamy
Journal:  Front Biosci       Date:  1997-11-01

2.  Human homolog of patched, a candidate gene for the basal cell nevus syndrome.

Authors:  R L Johnson; A L Rothman; J Xie; L V Goodrich; J W Bare; J M Bonifas; A G Quinn; R M Myers; D R Cox; E H Epstein; M P Scott
Journal:  Science       Date:  1996-06-14       Impact factor: 47.728

Review 3.  Immunological effects of ultraviolet radiation.

Authors:  M L Kripke
Journal:  J Dermatol       Date:  1991-08       Impact factor: 4.005

4.  Sunlight and skin cancer.

Authors:  D J Leffell; D E Brash
Journal:  Sci Am       Date:  1996-07       Impact factor: 2.142

Review 5.  Chromophore for UV-induced immunosuppression: DNA.

Authors:  A A Vink; D B Yarosh; M L Kripke
Journal:  Photochem Photobiol       Date:  1996-04       Impact factor: 3.421

6.  Cellular proofreading.

Authors:  D E Brash
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

7.  Fas ligand: a sensor for DNA damage critical in skin cancer etiology.

Authors:  L L Hill; A Ouhtit; S M Loughlin; M L Kripke; H N Ananthaswamy; L B Owen-Schaub
Journal:  Science       Date:  1999-08-06       Impact factor: 47.728

8.  Frequent clones of p53-mutated keratinocytes in normal human skin.

Authors:  A S Jonason; S Kunala; G J Price; R J Restifo; H M Spinelli; J A Persing; D J Leffell; R E Tarone; D E Brash
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

Review 9.  Modulation of immunity by ultraviolet radiation: key effects on antigen presentation.

Authors:  S E Ullrich
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

10.  Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome.

Authors:  H Hahn; C Wicking; P G Zaphiropoulous; M R Gailani; S Shanley; A Chidambaram; I Vorechovsky; E Holmberg; A B Unden; S Gillies; K Negus; I Smyth; C Pressman; D J Leffell; B Gerrard; A M Goldstein; M Dean; R Toftgard; G Chenevix-Trench; B Wainwright; A E Bale
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

View more
  5 in total

1.  [Basal cell carcinoma of the periocular region].

Authors:  F Geszti; D Hargitai; O Lukáts; H Győrffy; J Tóth
Journal:  Pathologe       Date:  2013-11       Impact factor: 1.011

2.  Grp1-associated scaffold protein regulates skin homeostasis after ultraviolet irradiation.

Authors:  Anand Venkataraman; Daniel J Coleman; Daniel J Nevrivy; Tulley Long; Chrissa Kioussi; Arup K Indra; Mark Leid
Journal:  Photochem Photobiol Sci       Date:  2014-01-09       Impact factor: 3.982

3.  Expression of metallothioneins in cutaneous squamous cell carcinoma and actinic keratosis.

Authors:  Aleksandra Zamirska; Łukasz Matusiak; Piotr Dziegiel; Grażyna Szybejko-Machaj; Jacek C Szepietowski
Journal:  Pathol Oncol Res       Date:  2012-03-10       Impact factor: 3.201

4.  Chemoprevention of skin cancer with 1,1-Bis (3'-indolyl)-1-(aromatic) methane analog through induction of the orphan nuclear receptor, NR4A2 (Nurr1).

Authors:  Cedar H A Boakye; Ravi Doddapaneni; Punit P Shah; Apurva R Patel; Chandraiah Godugu; Stephen Safe; Santosh K Katiyar; Mandip Singh
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

5.  Current research and development of chemotherapeutic agents for melanoma.

Authors:  Kyaw Minn Hsan; Chun-Chieh Chen; Lie-Fen Shyur
Journal:  Cancers (Basel)       Date:  2010-04-09       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.